1. Home
  2. TBLA vs TBPH Comparison

TBLA vs TBPH Comparison

Compare TBLA & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$3.15

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$14.76

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
TBPH
Founded
2007
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
TBLA
TBPH
Price
$3.15
$14.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$5.00
$18.50
AVG Volume (30 Days)
2.2M
830.5K
Earning Date
05-06-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
279.13
EPS
N/A
2.06
Revenue
N/A
$15,386,000.00
Revenue This Year
$7.63
$9.51
Revenue Next Year
$5.25
N/A
P/E Ratio
$42.36
$16.23
Revenue Growth
N/A
N/A
52 Week Low
$2.63
$7.90
52 Week High
$4.65
$21.03

Technical Indicators

Market Signals
Indicator
TBLA
TBPH
Relative Strength Index (RSI) 43.45 40.20
Support Level $3.13 $13.41
Resistance Level $3.50 $15.22
Average True Range (ATR) 0.14 0.44
MACD 0.02 0.14
Stochastic Oscillator 24.42 89.80

Price Performance

Historical Comparison
TBLA
TBPH

About TBLA Taboola.com Ltd.

Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: